Bridging the Translational Divides

Markers in Cancer 2012 (formerly known as the ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer) will stimulate discussion on the use of biomarkers as a tool for optimizing detection and treatment in oncology. 

Designed for clinicians, pathologists, clinical and translational researchers, statisticians, radiologists, and others who specialize in molecular diagnostics, the meeting will present the latest advances in cancer markers to assess drug efficacy, improve prognostic and predictive evaluations and imaging, and enhance clinical trial development.

This year's Meeting will focus on practice-oriented translational research. Join us in Florida to review and explore the latest innovations in cancer markers. Housing, Registration and Abstract Submissions will open in late April.

Diagnostic Development Tutorial
Developing Biomarkers for Oncology Practice:
From Hypothesis to Product
October 10-11, 2012

Prior to the Main Meeting, a one and a half-day tutorial open to selected early-career oncologists, industry and regulatory representatives will be held. The Tutorial will provide clinical decision making tools and diagnostic challenges in an interactive, team-based format with discussions and lectures led by distinguished faculty. Limited travel grant opportunities are available for academic participants.